Summary
We have observed two patients with AIDS suffering from severe watery diarrhea refractory to conventional medical treatment. In the first patient the reason for the diarrhea could not be revealed in spite of extensive investigations; however, the clinical picture suggested cryptosporidia infection. In the second patient cytomegalovirus could be shown in colonic biopsy specimens. After failure of several attempts of symptomatic, antibiotic, and antiviral therapy, the long-acting somatostatin analogue SMS 201-995 was administered to the patients subcutaneously in a dose between 2 × 50 µg and 3 × 100 µg/day. This treatment resulted in a prompt reduction of stool volume and bowel motions. Somatostatin may be a useful addition to the symptomatic treatment of refractory diarrhea in AIDS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133–1140
Bonfils S, Ruszniewski P, Costil V, Laucournet H, Vatier J, Rene E, Mignon M (1986) Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin. Lancet I:554–555
Ch'ng JL, Anderson JV, Williams SJ, Carr DH, Bloom SR (1986) Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long-acting somatostatin analogue. Br Med J 292:981–982
Cook DJ, Kelton JG, Stanisz AM, Collins SM (1988) Somatostatin treatment for cryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Int Med 108:708–709
Dharmsathaphorn K, Sherwin RS, Cataland S, Jaffe B, Dobbins J (1980) Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Int Med 92:68–69
Edwards CA, Cann PA, Read NW, Holdsworth CD (1985) Effect of somatostatin analogue SMS 201-995 on fluid and electrolyte transport in a patient with secretory diarrhea. Gut 25:A1115
Füeßl HS, Carolan G, Williams G, Bloom SR (1987) Effect of a long-acting somatostating analogue (SMS 201-995) on postprandial gastric emptying of99mTc-tin colloid and mouth-to caecum transit time in man. Digestion 36:101–107
Gelb A, Miller S (1986) AIDS and gastroenterology. Am J Gastroenterol 81:619–622
Kaplan LD, Wofsy CB, Volberding PA (1987) Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. JAMA 257:1367–1374
Krämer A, Riecken E-O (1986) Gastrointestinale Manifestationen beim erworbenen Immundefektsyndrome (AIDS). AIFO 1:405–420
Long RG, Christofides ND, Fitzpatrick ML, O'Shaughnessy DJ, Bloom SR (1982) Effects of intravenous somatostatin and motilin on the blood glucose and hormonal response to oral glucose in man. Eur J Clin Invest 12:331–336
Maton PN, O'Dorisio TM, Howe BA, McArthur KE, Howard HM, Cherner JA, Malarkey TB, Collen MJ, Gardner JD, Jensen RT (1985) Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med 312:17–21
Moskovitz BL, Stanton TL, Smith KE, Kusmierek JJE (1988) Spiramycin therapy for immunocompromised patients with cryptosporidial diarrhea. IV Int Conference on AIDS, Abstract 7126
Santangelo WC, O'Dorisio TM, Kim JG, Severino G, Krejs GJ (1985) Pancreatic cholera syndrome: effect of a synthetic somatostatin analogue on intestinal water and ion transport. Ann Int Med 103:363–367
Sheppard M, Shapiro B, Pimstone B, Kronheim MB, Gregory M (1979) The metabolic clearance and plasma half disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 49:50–53
Smith PD, Lane HC, Gill VJ, Manischewitz JF, Quinnan GV, Fauci AS, Masur H (1988) Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:328–333
Usadel KH, Kessler H, Rohr G, Kusterer K, Palitzsch KD, Schwedes U (1986) Cytoprotective properties of somatostatins. Klin Wochenschr [Suppl VII] 64:59–63
Williams NS, Cooper JC, Axon ATR, King RFGJ, Barker M (1984) Use of a long-acting somatostatin analogue in controlling life threatening ileostomy diarrhoea. Br Med J 289:1027–1028
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Füeßl, H.S., Zoller, W.G., Kochen, M.M. et al. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995. Klin Wochenschr 67, 452–455 (1989). https://doi.org/10.1007/BF01725142
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01725142